Gang Pei
Director/Board Member at Shanghai Industrial Pharmaceutical Investment Co. Ltd.
Network origin in Gang Pei first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Tongji University
45
| College/University | Other Consumer Services | 45 |
Shanghai Industrial Pharmaceutical Investment Co. Ltd.
 Shanghai Industrial Pharmaceutical Investment Co. Ltd. Pharmaceuticals: OtherHealth Technology Shanghai Industrial Pharmaceutical Investment Co. Ltd. is involved in the development, manufacturing and selling of pharmaceutical medicines and medical devices. The company was founded on July, 1981 with main headquarters in Shanghai, China.
10
| Subsidiary | Pharmaceuticals: Other | 10 |
Chinese Society For Cell Biology
2
| Private Company | 2 | |
Consortium For Globalization of Chinese Medicine
1
| Private Company | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Gang Pei via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| SHANGHAI INDUSTRIAL HOLDINGS LIMITED | Real Estate Development | Director/Board Member Director/Board Member | |
| SHANGHAI JINQIAO EXPORT PROCESSING ZONE DEVELOPMENT CO.,LTD | Real Estate Development | Director/Board Member | |
| SHANGHAI SHIMAO CO.,LTD | Real Estate Development | Director/Board Member Director/Board Member | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal | |
| SAIC MOTOR CORPORATION LIMITED | Motor Vehicles | Director/Board Member Director/Board Member | |
| WEICHAI POWER CO., LTD. | Auto Parts: OEM | Director/Board Member Director/Board Member | |
| CHANGJIANG & JINGGONG STEEL BUILDING (GROUP) CO., LTD | Metal Fabrication | Director/Board Member | |
| Iowa State University | College/University | Doctorate Degree | |
| SHANGHAI INTERNATIONAL AIRPORT CO., LTD. | Other Transportation | Director/Board Member Director/Board Member | |
| SHANGHAI TONGJI SCIENCE&TECHNOLOGY INDUSTRIAL CO.,LTD | Homebuilding | Chairman Director/Board Member | |
| SHANGHAI JIAO YUN GROUP CO., LTD. | Trucking | Director/Board Member | |
| Princeton University | College/University | Doctorate Degree | |
| XUEDA (XIAMEN) EDUCATION TECHNOLOGY GROUP CO., LTD | Real Estate Development | Director/Board Member Director/Board Member | |
| Tsinghua University | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| Shanghai Jiao Tong University | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree | |
| Fudan University | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Zhengzhou University | College/University | Undergraduate Degree | |
China Gas Association
 China Gas Association Gas DistributorsUtilities China Gas Association is a nonprofit organization, which engages in the production and distribution of gas. The company was founded in 2002 and is headquartered in Beijing, China. | Gas Distributors | Corporate Officer/Principal | |
| Jiangsu University | College/University | Director/Board Member | |
| RISEN ENERGY CO.,LTD. | Semiconductors | Director/Board Member | |
| CHINA RESOURCES GAS GROUP LIMITED | Gas Distributors | Director/Board Member | |
| China Ministry of Housing & Urban Rural Development | General Government | Corporate Officer/Principal | |
| Shanghai University | College/University | Masters Business Admin Director/Board Member | |
| Roche (China) Co. Ltd. | Chief Tech/Sci/R&D Officer | ||
| China Civil Engineering Society | Corporate Officer/Principal | ||
| SHENZHEN YSSTECH INFO-TECH CO.,LTD | Information Technology Services | Director/Board Member | |
| GUANGZHENG EYE HOSPITAL GROUP CO.,LTD. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Tongji Architectural Design (Group) Co., Ltd.
 Tongji Architectural Design (Group) Co., Ltd. Other Consumer ServicesConsumer Services Tongji Architectural Design (Group) Co., Ltd. engages in design of domestic and non domestic construction suveys, construction consulting, construction management services, and construction planning. The company was founded on April 25, 1995 and it is headquartered in Shanghai, China. | Other Consumer Services | Director/Board Member | |
| The Second Military Medical University | College/University | Doctorate Degree | |
| China Ministry of Education | General Government | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| China Steel Construction Society | Corporate Officer/Principal | ||
Coland Pharmaceutical Co., Ltd.
 Coland Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Coland Pharmaceutical is a specialty pharmaceutical company focusing on marketing branded products and developing solid pipelines through collaboration with leading institutes. Its main interests are in the dedicated therapeutic areas Hepatitis, Immunology, Oncology, and other niche areas. Coland was started its sales operation in 2005. Daiding (Adefovir), a first-to-market generic that treats HBV was launched in 2005. With effective promotion, and brand building, Daiding achieved great success and gained the leading position in China. Its goal is to become a leading specialty pharmaceutical company in China with strong sales and marketing capabilities and solid product pipelines. The company was founded in 2003 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Director/Board Member | |
| COLAND HOLDINGS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| HUA MEDICINE (SHANGHAI) LTD. | Pharmaceuticals: Major | Founder | |
| ZHEJIANG YONGGUI ELECTRIC EQUIPMENT CO., LTD. | Electronic Components | Director/Board Member | |
| NAIPU MINING MACHINERY CO., LTD. | Trucks/Construction/Farm Machinery | Director/Board Member | |
| Sino-American Pharmaceutical Professionals Association | President | ||
| CELLULAR BIOMEDICINE GROUP, INC. | Biotechnology | Director/Board Member | |
| Shanghai Automotive Engineering Association | Director/Board Member | ||
| JIANGSU JIEJIE MICROELECTRONICS CO., LTD. | Semiconductors | Director/Board Member | |
| University of Colorado Boulder | College/University | Corporate Officer/Principal | |
Intel China Research Ltd.
 Intel China Research Ltd. Miscellaneous Commercial ServicesCommercial Services Intel China Research Ltd. explores internet-related issues and information technology disciplines. The private company is based in Beijing, China. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Hua Medicine Technology (Hong Kong) Ltd. | Director/Board Member | ||
Hua Medicine (Shanghai) Co., Ltd.
 Hua Medicine (Shanghai) Co., Ltd. BiotechnologyHealth Technology Hua Medicine (Shanghai) Co., Ltd. is a Chinese biotechnology company that focuses on the clinical needs of diabetic patients. The private company is based in Shanghai, China. The company has brought together high-end talents and scientific and technological resources to develop the world's first dorzagliatin (hms5552) for the treatment of type 2 diabetes. Hua Medicine has conducted two phase III clinical trials in 2019, targeting type 2 diabetes patients who have failed to treat the disease with other medications. The company plans to expand the advanced concepts of personalized therapy and management of diabetes to achieve effective control of diabetes and metabolic diseases and complications. The company was founded in 2011 by Li Chen, who has been the CEO since then. | Biotechnology | Chief Executive Officer | |
| Roche R & D Center China Co. Ltd. | Chief Tech/Sci/R&D Officer | ||
| Tongji University School of Medicine | College/University | Corporate Officer/Principal | |
| CONCORD NEW ENERGY GROUP LIMITED | Electric Utilities | Director/Board Member | |
| University of Shanghai for Science & Technology | College/University | Corporate Officer/Principal | |
| East China Normal University | College/University | Corporate Officer/Principal |
Statistics
International
| China | 40 |
| United States | 8 |
| Hong Kong | 5 |
Sectoral
| Consumer Services | 15 |
| Health Technology | 7 |
| Finance | 5 |
| Producer Manufacturing | 4 |
| Utilities | 4 |
Operational
| Director/Board Member | 232 |
| Independent Dir/Board Member | 120 |
| Corporate Officer/Principal | 118 |
| Chairman | 43 |
| Doctorate Degree | 31 |
Most connected contacts
| Insiders | |
|---|---|
| Gérard Mestrallet | 34 |
| Chang Le Liu | 27 |
| Xin Jun Liang | 22 |
| Zhuo Ping Yu | 19 |
| Jian Xin You | 17 |
| Jie Liu | 16 |
| Lee Chan Hang | 15 |
| Jochem Peter Heizmann | 14 |
| Li Chen | 14 |
| Si Zong Wu | 13 |
| Guo Tong Xu | 11 |
| Chun Rong Liao | 11 |
| Chun Yan Liu | 11 |
| Di Ming Lou | 10 |
| Fang Zheng Chen | 10 |
- Stock Market
- Insiders
- Gang Pei
- Company connections
